Yaz, Other Birth Control Drugs Boost Blood Clot Risk: FDA

Law360, New York (October 27, 2011, 8:30 PM EDT) -- Women who take birth control pills like Bayer AG’s Yaz that contain the synthetic hormone drospirenone face a greater risk of developing dangerous blood clots than those who take low-estrogen contraceptives, the U.S. Food and Drug Administration said Thursday.

Women who took DRSP drugs were about 75 percent more likely to suffer from potentially fatal venous thromboembolism and similar conditions, the FDA said.

The announcement came in an update to the FDA’s ongoing study on the connection between blood clots and birth control drugs. The agency...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.